Improving the Mobility of Transportation Disadvantaged Older Adults

Sponsor
The University of Texas at Arlington (Other)
Overall Status
Completed
CT.gov ID
NCT05812105
Collaborator
Center for Transportation, Equity, Decisions and Dollars (Other), University of South Florida (Other)
25
1
1
6.4
3.9

Study Details

Study Description

Brief Summary

The primary objective of the research was to improve mobility for transportation-disadvantaged older adults by expanding the scope of the existing Healthy Buddy Program, to accommodate an aging Spanish-speaking population in the U.S.

Condition or Disease Intervention/Treatment Phase
  • Other: Healthy Buddy Program
N/A

Detailed Description

The research identified barriers and opportunities to improve Hispanic/Latino older adult access to community-based transportation and health resources. It was conducted with the existing Healthy Buddy model, which pairs older adults with college students who are trained to help them identify relevant transportation and health resources, while accommodating the unique needs of this transportation-disadvantaged population. The research team reevaluated the potential effectiveness of a Spanish-language accessible Healthy Buddy program model for increasing the self-efficacy and quality of life among Hispanic/Latino older adults. The team recruited bilingual (English-Spanish-speaking) students from multidisciplinary backgrounds. Older adult participants were invited to participate in pre- and post-surveys, including a qualitative interview, to allow the team to further evaluate the success of the program among Hispanic/Latino participants and to determine the replicability of the project in other communities with a significant population of transportation disadvantaged Hispanic/Latino older adults.

Study Design

Study Type:
Interventional
Actual Enrollment :
25 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
Participants received an intervention (i.e., Healthy Buddy Program providing a list of transportation/aging/health-related services available in their community) and complete pre- and post-surveys & interviews.Participants received an intervention (i.e., Healthy Buddy Program providing a list of transportation/aging/health-related services available in their community) and complete pre- and post-surveys & interviews.
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Improving the Mobility of Transportation Disadvantaged Older Adults A Community-Based Intervention for the Hispanic/Latino Population
Actual Study Start Date :
Oct 23, 2020
Actual Primary Completion Date :
May 6, 2021
Actual Study Completion Date :
May 6, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: Health Buddy Program

This intergenerational program targets Spanish speaking older adults who lack reliable and/or safe transportation and are managing at least one chronic illness. The program goal is to improve older adults' awareness of existing community resources, with an emphasis on transportation and health assets. Trained college students acted as facilitators for the program and helped older adults with relevant community resources.

Other: Healthy Buddy Program
The Healthy Buddy Program is a community-based initiative that pairs college students with transportation disadvantaged, community- dwelling older adults age 65 and older. The Spanish-language Healthy Buddy Program was developed to measure the transportation and health challenges of Hispanic/Latino older adults and determine the efficacy of the adapted HB program model.

Outcome Measures

Primary Outcome Measures

  1. Quality of life and well-being of older adults [4 weeks]

    The title of the scale is Brief Older People's Quality of Life questionnaire. It is the short, 13-item version of the original Older People's Quality of Life questionnaire. Each of the 13 items is scored Strongly agree=5, Agree=4, Neither=3, Disagree=2, Strongly disagree=1. The items are summed for a total score, so that higher scores represented higher quality of life. The score ranges from 13 to 65.

Secondary Outcome Measures

  1. Self-efficacy correlated to emotion, stress, and health complaints [4 weeks]

    The title of the scale is General Self-Efficacy scale. The General Self-Efficacy Scale has 10 items correlated to emotion, optimism, work satisfaction. Each item is scored Not at all true=1, Hardly true=2, Moderately true=3, and Exactly true=4. The total score is calculated by finding the sum of the all items.The total score ranges between 10 and 40, with a higher score indicating more self-efficacy.

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 99 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Older adults age 65+

  • Those who no longer drive

  • Resident of Texas

  • Those who manage at least one health condition (e.g., diabetes, high blood pressure, etc.)

  • Spanish is primary language

Exclusion Criteria:
  • Those who do not have a capacity to answer the pre-screening questions due to their cognitive and physical limitations

  • Hispanic individuals who can speak fluent English will be excluded because they may have a better understanding of existing resources and information written and serviced in English in the community.

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Texas at Arlington Arlington Texas United States 76019

Sponsors and Collaborators

  • The University of Texas at Arlington
  • Center for Transportation, Equity, Decisions and Dollars
  • University of South Florida

Investigators

None specified.

Study Documents (Full-Text)

More Information

Publications

Responsible Party:
Kathy Lee, Assistant Professor, The University of Texas at Arlington
ClinicalTrials.gov Identifier:
NCT05812105
Other Study ID Numbers:
  • 2020-0391
First Posted:
Apr 13, 2023
Last Update Posted:
Apr 18, 2023
Last Verified:
Apr 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Kathy Lee, Assistant Professor, The University of Texas at Arlington

Study Results

No Results Posted as of Apr 18, 2023